» Articles » PMID: 29146594

Heterologous Phosphorylation-induced Formation of a Stability Lock Permits Regulation of Inactive Receptors by β-arrestins

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2017 Nov 18
PMID 29146594
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

β-Arrestins are key regulators and signal transducers of G protein-coupled receptors (GPCRs). The interaction between receptors and β-arrestins is generally believed to require both receptor activity and phosphorylation by GPCR kinases. In this study, we investigated whether β-arrestins are able to bind second messenger kinase-phosphorylated, but inactive receptors as well. Because heterologous phosphorylation is a common phenomenon among GPCRs, this mode of β-arrestin activation may represent a novel mechanism of signal transduction and receptor cross-talk. Here we demonstrate that activation of protein kinase C (PKC) by phorbol myristate acetate, G-coupled GPCR, or epidermal growth factor receptor stimulation promotes β-arrestin2 recruitment to unliganded AT angiotensin receptor (ATR). We found that this interaction depends on the stability lock, a structure responsible for the sustained binding between GPCRs and β-arrestins, formed by phosphorylated serine-threonine clusters in the receptor's C terminus and two conserved phosphate-binding lysines in the β-arrestin2 N-domain. Using improved FlAsH-based serine-threonine clusters β-arrestin2 conformational biosensors, we also show that the stability lock not only stabilizes the receptor-β-arrestin interaction, but also governs the structural rearrangements within β-arrestins. Furthermore, we found that β-arrestin2 binds to PKC-phosphorylated ATR in a distinct active conformation, which triggers MAPK recruitment and receptor internalization. Our results provide new insights into the activation of β-arrestins and reveal their novel role in receptor cross-talk.

Citing Articles

Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors.

Toth A, Turu G, Hunyady L Nat Rev Nephrol. 2024; 20(11):722-741.

PMID: 39039165 DOI: 10.1038/s41581-024-00869-3.


Interactions between AT1R and GRKs: the determinants for activation of signaling pathways involved in blood pressure regulation.

Poonam , Chaudhary S Mol Biol Rep. 2023; 51(1):46.

PMID: 38158508 DOI: 10.1007/s11033-023-08995-0.


Allosteric Regulation of G-Protein-Coupled Receptors: From Diversity of Molecular Mechanisms to Multiple Allosteric Sites and Their Ligands.

Shpakov A Int J Mol Sci. 2023; 24(7).

PMID: 37047169 PMC: 10094638. DOI: 10.3390/ijms24076187.


Interactions between β-arrestin proteins and the cytoskeletal system, and their relevance to neurodegenerative disorders.

Szenasi T, Turu G, Hunyady L Front Endocrinol (Lausanne). 2023; 14:957981.

PMID: 36843600 PMC: 9947276. DOI: 10.3389/fendo.2023.957981.


β-arrestin1 and 2 exhibit distinct phosphorylation-dependent conformations when coupling to the same GPCR in living cells.

Haider R, Matthees E, Drube J, Reichel M, Zabel U, Inoue A Nat Commun. 2022; 13(1):5638.

PMID: 36163356 PMC: 9512828. DOI: 10.1038/s41467-022-33307-8.


References
1.
Gyombolai P, Boros E, Hunyady L, Turu G . Differential β-arrestin2 requirements for constitutive and agonist-induced internalization of the CB1 cannabinoid receptor. Mol Cell Endocrinol. 2013; 372(1-2):116-27. DOI: 10.1016/j.mce.2013.03.013. View

2.
Shenoy S, Lefkowitz R . Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes. J Biol Chem. 2005; 280(15):15315-24. DOI: 10.1074/jbc.M412418200. View

3.
Xiang B, Yu G, Guo J, Chen L, Hu W, Pei G . Heterologous activation of protein kinase C stimulates phosphorylation of delta-opioid receptor at serine 344, resulting in beta-arrestin- and clathrin-mediated receptor internalization. J Biol Chem. 2000; 276(7):4709-16. DOI: 10.1074/jbc.M006187200. View

4.
Paradis J, Ly S, Blondel-Tepaz E, Galan J, Beautrait A, Scott M . Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression. Proc Natl Acad Sci U S A. 2015; 112(37):E5160-8. PMC: 4577186. DOI: 10.1073/pnas.1508836112. View

5.
Overington J, Al-Lazikani B, Hopkins A . How many drug targets are there?. Nat Rev Drug Discov. 2006; 5(12):993-6. DOI: 10.1038/nrd2199. View